G. Schmidbauer

Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1

Stefan G. Tullius, Melina Nieminen-Kelhä, Roland Buelow et al. · Transplantation · 2002 · 177 citations

CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.

Jerzy W. Kupiec‐Weglinski, B Wa̧sowska, Ildikó Papp et al. · The Journal of Immunology · 1993 · 74 citations

Skin Grafts, Cell Therapy, Th1 Lymphokines +17

ABROGATION BY RAPAMYCIN OF ACCELERATED REJECTION IN SENSITIZED RATS BY INHIBITION OF ALLOANTIBODY RESPONSES AND SELECTIVE SUPPRESSION OF INTRAGRAFT MONONUCLEAR AND ENDOTHELIAL CELL ACTIVATION, CYTOKINE PRODUCTION, AND CELL ADHESION1,2

G. Schmidbauer, Wayne W. Hancock, B Wa̧sowska et al. · Transplantation · 1994 · 46 citations

Heart Failure, Immunology, Pharmacotherapy +24

Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.

K J Wieder, Wayne W. Hancock, G. Schmidbauer et al. · The Journal of Immunology · 1993 · 40 citations · Full text

Rapamycin Treatment, Immunology, Cardiac Allografts +22

Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors1

Anja Reutzel‐Selke, Thomas Zschockelt, Christian Denecke et al. · Transplantation · 2003 · 29 citations